A prospective open label randomised controlled trial of Ayurvedic intervention in asymptomatic and mild symptomatic cases of COVID-19 - SEM-20

Ministry of AYUSH0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Individuals of either sex above the age of 15 years to 65 years.
•2.Subjects testing positive for SARS CoV-2 by RT-PCR, presenting with no symptoms or mild symptoms (as defined by US-CDC).
•3.Subjects who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study

•1.Cases of COVID-19 with clinical severity ranging from moderate to critical (as defined by US-CDC).
•2.Pregnant and Lactating females.
•3.Subjects having uncontrolled and unstable co morbidities.
•4.Immunocompromised subjects or those taking any kind of immunosuppressive therapy.
•5.COVID-19 positive cases participating as subjects in other COVID-19 clinical trials.
•6.Subjects having a past history of allergy to any medicine that is part of the Ayurvedic intervention. Other conditions, which in the opinion of the investigators, makes the patient unsuitable for enrolment or could interfere with his participation in, and completion of the protocol.

发起方